(2023)
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis.
J Clin Invest ,
e161593.

Dr. Matthew Blango
RNA-Biologie der Pilzinfektionen · Leiter +49 3641 532-1072 matthew.blango@leibniz-hki.dePublikationen
(2022)
A tRNA modifying enzyme as a tunable regulatory nexus for bacterial stress responses and virulence.
Nucleic Acids Res 50(13),
7570-7590.
(2022)
Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth.
mBio 13(1),
e0356321.
(2022)
Functional characterization of the RNA interference pathway in A. fumigatus reveals its potential for antifungal therapy.
bioRxiv
[Preprint]
(2022)
PLB-985 neutrophil-like cells as a model to study Aspergillus fumigatus pathogenesis.
mSphere 7(1),
e0094021.
(2021)
Host-derived extracellular vesicles for antimicrobial defense.
microLife 2,
uqab003.
(Review)
(2021)
RNA-based therapeutics to treat human fungal infections.
Trends Microbiol 30(5),
411-420.
(Review)
(2020)
Dynamic surface proteomes of allergenic fungal conidia.
J Proteome Res 19(5),
2092-2104.
(2020)
Functional surface proteomic profiling reveals the host heat-shock protein A8 as a mediator of Lichtheimia corymbifera recognition by murine alveolar macrophages.
Environ Microbiol 22(9),
3722-3740.
(2020)
Biotinylated surfome profiling identifies potential biomarkers for diagnosis and therapy of Aspergillus fumigatus infection.
mSphere 5(4),
e00535-20.